Nomenclature
CAS number: 541-19-5
O,O-Succinyldicholine iodide; diacetylcholine iodide; diacetylcholine diiodide; suxamethonium iodide; bis(β-dimethylaminoethyl)succinate bis(methyl iodide); Celocurine (Pfizer).
C
14H
30I
2N
2O
4; mol wt 544.21.
C 30.90%, H 5.56%, I 46.64%, N 5.15%, O 11.76%.
Description and references
Prepd by reacting β-bromoethyl succinate with
trimethylamine: Glick, J. Biol. Chem. 137, 357 (1941); Fusco et al., Gazz. Chim. Ital. 79, 129, 837
(1949); Walker, J. Chem. Soc. 1950, 193. Succinic acid chloride may be coupled with choline
chloride directly or with dimethylaminoethanol, followed by quaternization
with methyl iodide: Tammelin, Acta Chem.
Scand. 7, 185 (1953). A third method is to
start with the diethyl ester of succinic acid, then bring about the
exchange reaction with dimethylaminoethanol, and quaternize with methyl
iodide: Phillips, J. Am. Chem. Soc. 71, 3264 (1949).
Properties
Slightly hygroscopic crystals, mp 243-245°. Freely sol in water
or normal saline, giving solns which are very slightly acidic. Most
stable at pH 4-5. Aq solns undergo progressive hydrolysis with corresp
loss of activity and increase in acidity. Prepare solns just before using. Incompatible with solns
of alkaline salts.Therapeutic Category
Neuromuscular blocking agent.
Therapeutic Category (Veterinary)
Muscle relaxant (skeletal).
Keywords
Neuromuscular Blocking Agent; Depolarizing Agents